<p>The Indian Council of Medical Research (ICMR) has conducted four serosurveys in India so far, the latest of which was done between June 14 and July 6 and stated that two-thirds of Indians have developed antibodies against Covid-19, but 40 crore are still vulnerable.</p>.<p>It also stated 67.6 per cent of India's population aged above six years has developed antibodies for Covid-19.</p>.<p><strong>Also Read — <a href="https://www.deccanherald.com/national/majority-in-big-states-have-covid-19-antibodies-survey-1013866.html" target="_blank">Majority in big states have Covid-19 antibodies: Survey</a></strong></p>.<p>Here's a look at what seroprevalence and serosurveys mean.</p>.<p><strong>What are serology and seroprevalence?</strong></p>.<p>Serology is the study of antibodies in blood serum. Antibodies are part of the human body's immune response to an infection or virus, like SARS-CoV-2. Covid-19's antibodies are detectable usually within the first few weeks after infection.</p>.<p>The presence of antibodies in a person means they were infected with the virus, irrespective of whether they had severe, mild, or no symptoms.</p>.<p>Seroprevalence is determined by a study conducted to measure the extent of an infection, measured by level of antibodies, in a population. The percentage of individuals in a population who have antibodies to infection is called seroprevalence. With a new virus, including Covid-19, initial seroprevalence is assumed to be low as the virus has not circulated before.</p>.<p>A positive result from a serology test may mean that a person was previously infected with the virus.</p>.<p><strong>Why is this study done?</strong></p>.<p>This testing helps determine the size of the outbreak of a disease or the extent to which a certain population has been infected or exposed to an infection. It helps capture unrecognised cases not detected during routine surveillance.</p>
<p>The Indian Council of Medical Research (ICMR) has conducted four serosurveys in India so far, the latest of which was done between June 14 and July 6 and stated that two-thirds of Indians have developed antibodies against Covid-19, but 40 crore are still vulnerable.</p>.<p>It also stated 67.6 per cent of India's population aged above six years has developed antibodies for Covid-19.</p>.<p><strong>Also Read — <a href="https://www.deccanherald.com/national/majority-in-big-states-have-covid-19-antibodies-survey-1013866.html" target="_blank">Majority in big states have Covid-19 antibodies: Survey</a></strong></p>.<p>Here's a look at what seroprevalence and serosurveys mean.</p>.<p><strong>What are serology and seroprevalence?</strong></p>.<p>Serology is the study of antibodies in blood serum. Antibodies are part of the human body's immune response to an infection or virus, like SARS-CoV-2. Covid-19's antibodies are detectable usually within the first few weeks after infection.</p>.<p>The presence of antibodies in a person means they were infected with the virus, irrespective of whether they had severe, mild, or no symptoms.</p>.<p>Seroprevalence is determined by a study conducted to measure the extent of an infection, measured by level of antibodies, in a population. The percentage of individuals in a population who have antibodies to infection is called seroprevalence. With a new virus, including Covid-19, initial seroprevalence is assumed to be low as the virus has not circulated before.</p>.<p>A positive result from a serology test may mean that a person was previously infected with the virus.</p>.<p><strong>Why is this study done?</strong></p>.<p>This testing helps determine the size of the outbreak of a disease or the extent to which a certain population has been infected or exposed to an infection. It helps capture unrecognised cases not detected during routine surveillance.</p>